Zhefeng Meng | Evolutionary Biology | Best Researcher Award

Dr. Zhefeng Meng | Evolutionary Biology | Best Researcher Award

Diretor at Fudan University, China

Dr. Zhefeng Meng (PhD, MD) is an accomplished Associate Professor and Deputy Director of the Scientific Research Department at Minhang Hospital, Fudan University. With over two decades of research experience, his work spans HIV molecular evolution, viral-host interactions, cancer biomarker discovery, and tumor immunology. He has published extensively in leading journals such as J Hepatol, J Infect Dis, Front Immunol, and Cell Death & Disease, contributing significantly to both basic and translational biomedical sciences. Dr. Meng has secured multiple competitive research grants from the National Natural Science Foundation of China, Shanghai Science and Technology Commission, and various postdoctoral programs. His scientific excellence has earned him numerous honors, including the Leading Talent Award of Minhang District and prestigious international travel and scholarship grants. His current research focuses on improving early cancer diagnostics and advancing immunotherapeutic strategies, positioning him as a key contributor to global efforts in infectious disease control and cancer research.

Professional Profile 

🎓 Education Background of Dr. Zhefeng Meng

Dr. Zhefeng Meng has built a strong and multidisciplinary academic foundation in medical sciences. He earned his Ph.D. in Medical Molecular Virology from the National Center for AIDS and STD Control and Prevention (China CDC) between 2005 and 2008, focusing on HIV gene variation and evolution. Prior to this, he completed a Master’s degree in Medical Molecular Biology at Wenzhou Medical College from 2001 to 2004, where he conducted research on fusion proteins and gene expression. His academic journey began with a College Diploma in Clinical Laboratory Medicine at Hubei College of Traditional Chinese Medicine from 1996 to 1999. This diverse educational background laid a solid foundation for his future contributions in virology, oncology, and immunology.

💼 Professional Experience of Dr. Zhefeng Meng

Dr. Zhefeng Meng has amassed extensive professional experience across leading medical and research institutions. Since 2015, he has served as an Associate Professor and Deputy Director of the Scientific Research Department at Minhang Hospital, Fudan University, where he leads cutting-edge studies on HIV recombination, syphilis and influenza evolution, and cancer biomarkers. Prior to this, from 2010 to 2015, he worked as an Associate Professor at the Shanghai Public Health Clinical Center, also affiliated with Fudan University, focusing on HIV-host protein interactions and viral replication mechanisms. From 2008 to 2010, Dr. Meng undertook postdoctoral research under Prof. Yumei Wen at Fudan University’s Key Laboratory of Medical Molecular Virology, where he studied therapeutic vaccines and HIV gene mutations. His earlier roles include Ph.D. research at China CDC, research assistantship at Taizhou Hospital, and work in the biotech industry, all of which contributed to his development as a versatile and impactful researcher in infectious diseases and oncology.

🔬 Research Interests of Dr. Zhefeng Meng

Dr. Zhefeng Meng’s research interests lie at the intersection of virology, immunology, and oncology, with a strong focus on infectious disease pathogenesis and tumor biology. He is particularly interested in the genetic evolution, recombination, and functional mutations of HIV, as well as their impact on viral infectivity, immune evasion, and host interactions. His work extends to studying early diagnostic biomarkers for liver and colorectal cancers, aiming to improve cancer detection and treatment strategies. Additionally, Dr. Meng explores the immune regulatory roles of viral proteins and develops novel immunotherapeutic approaches, such as peptide-based vaccines and fusion proteins. His interdisciplinary approach integrates molecular biology, clinical research, and translational science to address pressing global health challenges.

🏅 Awards and Honors of Dr. Zhefeng Meng

Dr. Zhefeng Meng has been widely recognized for his outstanding contributions to biomedical research through numerous national and international awards. He was honored as one of the Leading Talents of Minhang District in 2018 and received the First Rank Zhejiang Provincial Award for Medical and Health Technology Innovation in 2012. His excellence as a young scientist was acknowledged with Young Investigator Scholarships at both AIDS 2012 and AIDS Vaccine 2012, and he earned travel grants for global virology symposiums. Earlier in his career, he was named a Top PhD Student at China CDC and received multiple provincial awards for science and technology innovations. His consistent academic excellence was also marked by honors such as the Kwang-Hua Scholarship, Top Graduate Student distinction from Wenzhou Medical College, and leadership awards during his undergraduate years. These accolades reflect Dr. Meng’s sustained impact, innovation, and leadership in the fields of virology and medical science.

Conclusion 

Dr. Zhefeng Meng is a highly accomplished biomedical researcher with a sustained and impactful contribution to infectious disease research, oncology, and molecular medicine. His work is scientifically rigorous, clinically relevant, and nationally recognized. With high-quality publications, funded research projects, and strong institutional leadership, he exemplifies the criteria for the Best Researcher Award.

📄 Publication Top Noted

  1. Title: TLR10 expression in unswitched memory B associates with the disease activity of patients with systemic lupus erythematosus
    Authors: Lumin Zhang, Linchang Yu, Quanfu Li, Meiping Ni, Qiongzhu Dong, Yufang Bao, Jinguan Zhang, Danping Ruan, Zhefeng Meng*, Nannan Lai
    Journal: Clinical Rheumatology
    Year: 2025
    Citations: 3

  2. Title: Nesfatin-1 regulates the HMGB1-TLR4-NF-κB signaling pathway to inhibit inflammation and its effects on the random skin flap survival in rats
    Authors: [Not fully visible]
    Journal: International Immunopharmacology
    Year: 2023
    Citations: 7

  3. Title: Roxadustat promotes hypoxia-inducible factor-1α/vascular endothelial growth factor signalling to enhance random skin flap survival in rats
    Authors: [Not fully visible]
    Journal: International Wound Journal
    Year: 2023
    Citations: 9

  4. Title: Saxagliptin promotes random skin flap survival
    Authors: [Not fully visible]
    Journal: International Immunopharmacology
    Year: 2023
    Citations: 10

  5. Title: Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues
    Authors: Yu T, Zhang M, Zhang H, Zheng J, Shen C, Jiang N, Zou L, Wang J, Yu Y, Zhang Q, Yu S, Huang Y, Huang Y, Zhang J, Qiu C*, Zhang W*, Meng Z*.
    Journal: Journal of Infectious Diseases
    Year: 2023
    Citations: 6

 

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. 🐖📈 Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. 🇳🇴🔬 He also serves part-time as a church servant at Uranienborg Menighet since 2020. ⛪ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). 🛡️🏥 With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. 🎓🌍 His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. 🦠📖 A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. 🏆✨

Publication  Profile

Orcid

Education 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. 🎓🐾 He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. 🇳🇴📚 He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. 🇺🇸📊 Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. 🇦🇺🩺 His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. 🏅🌟

Experience 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. 🐷📊 In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. ⛪ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. 🐔🔍 He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). 🎖️🚛 These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. 🏅📈

Awards and Honors 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. 🐾📈 His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. 🦠🔬 His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. 🇳🇴🐖 Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. 🎖️🌏 Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. 🏅📚 His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research Focus 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. 🐖🦠 His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. 📊🛡️ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. 📈🖥️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. 🧬🔍 Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. 📑📈 His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. 🏆🔬 His work supports healthier livestock systems and contributes to global food security. 🌍🍖

Publications Top Notes

  • 📄 “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • 📄 “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • 📄 “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • 📄 “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • 📄 “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • 📄 “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Hiranmoy Das | Biology and Life Sciences | Lifetime achievement Award

Prof Hiranmoy Das, Texas Tech University Health Sciences Center, United States

Prof. Hiranmoy Das, MSc, PhD, FAHA, is a renowned biochemist and pharmacologist with a distinguished career. He holds a Ph.D. from the University of Calcutta and has postdoctoral training from prestigious institutions like Harvard Medical School and the Hyogo Institute of Clinical Research. Currently a Professor at Texas Tech University, his research focuses on cardiovascular stem cell therapies, regenerative medicine, and immunology. He has received numerous awards, including induction into the National Academy of Inventors and the American Heart Association. Prof. Das has authored several publications and holds multiple patents. 🌟📚💉🔬🧬

Publication Profile

Google Scholar

Education

Prof. Hiranmoy Das holds a Ph.D. in Biochemistry from the University of Calcutta (1995) and has extensive academic training in zoology, advanced cytogenetics, immunology, and biology. He completed postdoctoral fellowships at prestigious institutions, including Harvard Medical School (1999-2002) and Hyogo Institute of Clinical Research, Japan (1996-1999). Prof. Das has held prominent roles, such as Professor at Texas Tech University (2016-present) and Associate Professor at The Ohio State University (2008-2016). He also directed cardiovascular stem cell research laboratories. His remarkable career spans over decades, focusing on innovative research in the fields of biochemistry and immunology. 📚💉🔬

Honors and Awards

Prof. Hiranmoy Das, a distinguished researcher and educator, has received numerous accolades for his groundbreaking contributions. In 2024, he was elected as a Fellow of the National Academy of Inventors. He was inducted into the prestigious Sigma Xi in 2023 and awarded the President’s Excellence in Research Award in 2022. As a tenured professor at Texas Tech University, he earned the Chancellor’s Council Distinguished Research Award in 2021. His honors also include the American Heart Association Fellowship (2021) and a Keynote Speaker role at an International Conference in 2018. Earlier awards include the NIH K01 Award and National Merit Scholarship. 🏆🔬🎓

Experiences

Prof. Hiranmoy Das has taught a variety of undergraduate, graduate, and professional courses at TTUHSC, including leadership roles in Pharmaceutical Sciences Research (G) in Spring, Summer, and Fall sessions from 2021 to 2024 📚. He led courses like Clinical Correlation-6 and Integrated Therapy and Practice VII, as well as Experimental Design and Biostatistics 🧪. Prof. Das has mentored students in clinical and research settings, contributing significantly to pharmaceutical education 💡. His commitment to fostering academic growth is reflected in his continued leadership in research-focused courses, impacting future professionals in the field of pharmaceutical sciences 🎓.

PhD Thesis

Prof. Hiranmoy Das appears to be heavily involved in mentoring and advising graduate students, particularly in the fields related to pharmacy, veterinary medicine, and health sciences. His research likely focuses on advanced pharmaceutical sciences, drug development, and therapeutics. With his role in advising students pursuing PhD and MS theses, his research could be centered around pharmaceutical applications, medicinal chemistry, or pharmacology. Given his involvement in both veterinary and pharmacy programs, his research may also bridge the gap between human and veterinary health, focusing on biomedical sciences, drug formulations, and therapeutics for both sectors. 📚💊🐾👩‍🔬👨‍🔬

Research Focus

Hiranmoy Das focuses on molecular and cellular biology, particularly related to vascular biology, immunology, and inflammation. His research delves into the roles of Kruppel-like factor 2 (KLF2) in endothelial cells, immune responses, and its regulatory functions in cardiovascular health. He also investigates autophagy, cell death, and ischemic stroke therapies, emphasizing the use of assays for monitoring these processes. His work highlights the role of phytochemicals in cancer prevention and the immune system’s effector functions. Das has made significant contributions to understanding cellular signaling and disease mechanisms, with implications for therapeutic development. 🔬💉🧬🫀

Publication Profile

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes

Current advances in ischemic stroke research and therapies

MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function

Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells

Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes

CD1-mediated γ/δ T cell maturation of dendritic cells

 

 

Salwa Bouabdallah | Biology and Life Sciences | Best Researcher Award

Salwa Bouabdallah | Biology and Life Sciences | Best Researcher Award

Dr salwa Bouabdallah, Faculty of science of bizerta, Tunisia

Dr. Salwa Bouabdallah is a distinguished researcher in Biological Sciences, earning her Ph.D. with distinction from the University of Carthage, Tunisia. With postdoctoral experience in Romania, she teaches biochemistry, neurophysiology, and biostatistics across several universities. Her innovative research focuses on behavioral neurophysiology and the therapeutic potential of natural compounds, including the health effects of Tribulus terrestris and its relevance to Alzheimer’s disease. Recognized with awards like the First Prize at the International Congress on Bioactive Molecules, Dr. Bouabdallah is dedicated to advancing scientific knowledge and mentoring future researchers. 🌱📚🔬🏆

Publication Profile

Orcid

University Degrees

Dr. Salwa Bouabdallah has a distinguished academic background in biological sciences. She earned her Ph.D. with distinction in Biological Sciences from the University of Carthage, Tunisia (2013-2016). Prior to that, she obtained a Master’s Degree in Research in Molecular and Cellular Plant Physiology from the University of Tunis El Manar (2010-2012) and another Master’s Degree in Life Sciences from the Virtual University of Tunis (2004-2009). Her educational journey began with a Higher Technician Diploma in Public Health (1991-1993) and a Baccalaureate Diploma in Mathematics and Science (1990). Her extensive qualifications highlight her commitment to advancing scientific knowledge. 🎓🌱🔬

Professional Experience

Dr. Salwa Bouabdallah has held numerous prestigious research and teaching positions from 2017 to 2024, including postdoctoral researcher roles at the Faculty of Science of Bizerta and Hospital HC-N. She has been an adjunct lecturer, teaching biochemistry, neurophysiology, and biostatistics, while also developing teaching materials and supervising Master’s and PhD students in Biology. With a strong background in public health, Dr. Bouabdallah worked as a Senior Technician in Medical Imaging from 1995 to 2008, training students in MRI applications. Her commitment to education is further highlighted by her participation in scientific events and training on digital pedagogy. 🎓🧬🩺📚

Awards and Honors

Dr. Salwa Bouabdallah has received significant recognition for her contributions to the field of biological sciences. In 2014, she was awarded the First Prize at the 1st International Congress on Bioactive Molecules, Functional Foods, and Oxidative Stress-Related Diseases held in Hammamet, showcasing her outstanding research impact. Additionally, she was honored as a Eugen UNESCO Fellowship Laureate for her postdoctoral work from 2022 to 2023, further emphasizing her commitment to advancing scientific knowledge. These accolades highlight her dedication and excellence in research, making her a prominent figure in her field. 🏆🌱📚🌍

Technical and Professional Skills

Dr. Salwa Bouabdallah has extensive expertise in behavioral neurophysiology, employing zebrafish models for various tests, including Y-maze, Novel Tank Test, and T-maze assessments. Her research focuses on identifying theranostic biomarkers for innovative and personalized therapies and utilizing molecular docking modeling to explore interactions between physiological receptors and bioactive natural substances. She is skilled in in vitro cell culture and cytotoxic testing, measuring oxidative stress biomarkers, and extracting DNA and RNA from various tissues. Additionally, Dr. Bouabdallah is proficient in characterizing and valorizing bioactive molecules from Tunisian flora using advanced techniques like HPLC and GC-MS. 🧬🌿🔬📊🌱

Research Focus

Dr. Salwa Bouabdallah’s research focuses on the intersection of natural compounds and their therapeutic potential, particularly in neuropharmacology and cancer treatment. She explores the bioactive properties of plants like Tribulus terrestris, examining their effects on neurological disorders such as Alzheimer’s and their anticancer activities. Her work includes behavioral neurophysiology testing in zebrafish, molecular docking studies, and the identification of theranostic biomarkers for personalized therapies. Additionally, Dr. Bouabdallah investigates the chemical profiles and health benefits of natural products, contributing significantly to the fields of molecular plant physiology, public health, and phytochemistry. 🌿🔬📚🧬💊

Publication Top Notes

Efficacy of Tribulus terrestris on diabetes and sexual disorders: A narrative review

Important Antihistaminic Plants and Their Potential Role in Health.

Sustainable Extraction, Chemical Profile, Cytotoxic and Antileishmanial Activities In-Vitro of Some <i>Citrus</i> Species Leaves Essential Oils

Separation and evaluation of natural antileishmanial potential against Leishmania major and infuntum isolated from the Tunisia strains

Current approaches and challenges for chemical characterization of inhibitory effect against cancer cell line isolated from Gokshur extract

Conclusion

Given her impressive track record of achievements, commitment to research and education, and significant contributions to her field, Dr. Salwa Bouabdallah is highly deserving of the Best Researcher Award.